
Acadia Pharmaceuticals’ DAYBUE™ (trofinetide) Receives FDA Approval for Rett Syndrome Treatment
Neuren Pharmaceuticals has announced that its North American partner, Acadia Pharmaceuticals, has been granted FDA approval for the use of DAYBUE™ (trofinetide) in treating Rett syndrome among pediatr ...